IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
(Q34795777)
scientific article
scientific article
Language:
other details
| description | scientific article |
External Links
| (P356) |
10.1136/ARD.2008.092932
|
| (P698) |
18625622
|
| (P932) |
3811149
|
| (P5875) |
5225994
|
| (P6179) |
1046657277
|